1. American College of O, Gynecologists Committee on Practice B-O. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001; 98: 525-538.
2. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004; 27 Suppl 1:S88-90. [
DOI:10.2337/diacare.27.2007.S88]
3. Ethier-Chiasson M, Forest JC, Giguère Y, Masse A, Marseille-Tremblay C, et al. Modulation of placental protein expression of OLR1: implication in pregnancy-related disorders or pathologies. Reproduction. 2008; 136: 491-502. [
DOI:10.1530/REP-08-0082]
4. Nakhjavani M, Asgharani F, Khalilzadeh O, Esteghamati A, Ghaneei A, Morteza A, et al. Oxidized low-density lipoprotein is negatively correlated with lecithin-cholesterol acyltransferase activity in type 2 diabetes mellitus. Am J Med Sci 2011; 341: 92-95. [
DOI:10.1097/MAJ.0b013e3181f3ce10]
5. Stephens JW, Gable DR, Hurel SJ, Miller GJ, Cooper JA, Humphries SE. Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clin Chem 2006; 52: 446-452. [
DOI:10.1373/clinchem.2005.060194]
6. Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, et al. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 2004; 53: 297-302. [
DOI:10.1016/j.metabol.2003.10.009]
7. Woodman RJ, Watts GF, Playford DA, Best JD, Chan DC. Oxidized LDL and small LDL particle size are independently predictive of a selective defect in microcirculatory endothelial function in type 2 diabetes. Diabetes Obes Metab 2005; 7: 612-617. [
DOI:10.1111/j.1463-1326.2005.00478.x]
8. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabetic medicine: Diabet Med 2004; 21: 103-113. [
DOI:10.1046/j.1464-5491.2003.00985.x]
9. Otero P, Herrera E, Bonet B. Dual effect of glucose on LDL oxidation: dependence on vitamin E. Free Radic Biol Med 2002; 33: 1133-1140. [
DOI:10.1016/S0891-5849(02)01002-X]
10. American Diabetes A. Standards of medical care in diabetes--2013. Diabetes Care 2013; 36 Suppl 1: S11-66. [
DOI:10.2337/dc13-S011]
11. Toescu V, Nuttall SL, Martin U, Nightingale P, Kendall MJ, Brydon P, et al. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci (Lond) 2004; 106: 93-98. [
DOI:10.1042/CS20030175]
12. Kanne JP, Lalani TA, Fligner CL. The placenta revisited: radiologic-pathologic correlation. Curr Probl Diagn Radiol 2005; 34: 238-255. [
DOI:10.1067/j.cpradiol.2005.08.001]
13. Ethier-Chiasson M, Forest JC, Giguere Y, Masse A, Marseille-Tremblay C, Levy E, et al. Modulation of placental protein expression of OLR1: implication in pregnancy-related disorders or pathologies. Reproduction 2008; 136: 491-502. [
DOI:10.1530/REP-08-0082]
14. Sanchez-Vera I, Bonet B, Viana M, Quintanar A, Martin MD, Blanco P, et al. Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity. Metabolism 2007; 56: 1527-1533. [
DOI:10.1016/j.metabol.2007.06.020]
15. Levitan I, Volkov S, Subbaiah PV. Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxid Redox Signal 2010; 13: 39-75. [
DOI:10.1089/ars.2009.2733]
16. Scazzocchio B, Vari R, D'Archivio M, Santangelo C, Filesi C, Giovannini C, et al. Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases. J Lipid Res 2009; 50: 832-845. [
DOI:10.1194/jlr.M800402-JLR200]
17. Gokulakrishnan K, Deepa R, Velmurugan K, Ravikumar R, Karkuzhali K, Mohan V. Oxidized low-density lipoprotein and intimal medial thickness in subjects with glucose intolerance: the Chennai Urban Rural Epidemiology Study-25. Metabolism 2007; 56: 245-250. [
DOI:10.1016/j.metabol.2006.10.002]
18. Nakhjavani M, Khalilzadeh O, Khajeali L, Esteghamati A, Morteza A, Jamali A, et al. Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol. Lipids 2010; 45: 321-327. [
DOI:10.1007/s11745-010-3401-8]
19. Schwenke DC, D'Agostino RB Jr, Goff DC, Jr, Karter AJ, Rewers MJ, Wagenknecht LE, et al. Differences in LDL oxidizability by glycemic status: the insulin resistance atherosclerosis study. Diabetes Care 2003; 26: 1449-1455. [
DOI:10.2337/diacare.26.5.1449]
20. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615-1625. [
DOI:10.2337/diabetes.54.6.1615]
21. Nakhjavani M, Esteghamati A, Khalilzadeh O, Asgarani F, Mansournia N, Abbasi M. Association of macroalbuminuria with oxidized LDL and TGF-beta in type 2 diabetic patients: a case-control study. Int Urol Nephrol 2010; 42: 487-492. [
DOI:10.1007/s11255-009-9643-9]
22. Renie G, Maingrette F, Li L. Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1). Curr Diabetes Rev 2007; 3: 103-110. [
DOI:10.2174/157339907780598225]